相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Interaction between alpha-synuclein and tau in Parkinson's disease Comment on Wills et al.: Elevated tauopathy and alpha-synuclein pathology in postmortem Parkinson's disease brains with and without dementia. Exp Neurol 2010; 225: 210-218
Kurt A. Jellinger
EXPERIMENTAL NEUROLOGY (2011)
Tauopathic Changes in the Striatum of A53T α-Synuclein Mutant Mouse Model of Parkinson's Disease
Jonathan Wills et al.
PLOS ONE (2011)
Does corticobasal degeneration exist? A clinicopathological re-evaluation
Helen Ling et al.
BRAIN (2010)
Elevated tauopathy and alpha-synuclein pathology in postmortem Parkinson's disease brains with and without dementia
Jonathan Wills et al.
EXPERIMENTAL NEUROLOGY (2010)
GSK3: A possible link between beta amyloid peptide and tau protein
Felix Hernandez et al.
EXPERIMENTAL NEUROLOGY (2010)
Tauopathies with parkinsonism: clinical spectrum, neuropathologic basis, biological markers, and treatment options
A. C. Ludolph et al.
EUROPEAN JOURNAL OF NEUROLOGY (2009)
α-Synuclein contributes to GSK-3β-catalyzed Tau phosphorylation in Parkinson's disease models
Tetyana Duka et al.
FASEB JOURNAL (2009)
Progressive supranuclear palsy: clinicopathological concepts and diagnostic challenges
David R. Williams et al.
LANCET NEUROLOGY (2009)
Role of Synucleins in Alzheimer's Disease
Leslie Crews et al.
NEUROTOXICITY RESEARCH (2009)
Hyperphosphorylation of Microtubule-Associated Protein Tau: A Promising Therapeutic Target for Alzheimer Disease
C. -X. Gong et al.
CURRENT MEDICINAL CHEMISTRY (2008)
Proline-directed Pseudo-phosphorylation at AT8 and PHF1 Epitopes Induces a Compaction of the Paperclip Folding of Tau and Generates a Pathological (MC-1) Conformation
Sadasivam Jeganathan et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2008)
Regulated interactions of the norepineprhine transporter by the actin and microtubule cytoskeletons
Alexis M. Jeannotte et al.
JOURNAL OF NEUROCHEMISTRY (2008)
Phosphorylation of tau and α-synuclein in synaptic-enriched fractions of the frontal cortex in Alzheimer's disease, and in Parkinson's disease and related α-synucleinopathies
G. Muntane et al.
NEUROSCIENCE (2008)
The many faces of corticobasal degeneration
Pettarusp M. Wadia et al.
PARKINSONISM & RELATED DISORDERS (2007)
Frontotemporal dementia with tau pathology
Laura Gasparini et al.
NEURODEGENERATIVE DISEASES (2007)
New developments of brain imaging for Parkinson's disease and related disorders
Paola Piccini et al.
MOVEMENT DISORDERS (2006)
Alpha-Synuclein induces hyperphosphorylation of Tau in the MPTP model of Parkinsonism
Tetyana Duka et al.
FASEB JOURNAL (2006)
The neurotoxin, MPP+,, induces hyperphosphorylation of Tau, in the presence of α-synuclein, in SH-SY5Y neuroblastoma cells
Tetyana Duka et al.
NEUROTOXICITY RESEARCH (2006)
In vivo magnetic resonance volumetric and spectroscopic analysis of mouse prostate cancer models
ST Fricke et al.
PROSTATE (2006)
Highly potent and specific GSK-3β inhibitors that block Tau phosphorylation and decrease α-synuclein protein expression in a cellular model of Parkinson's disease
Alan P. Kozikowski et al.
CHEMMEDCHEM (2006)
The mitochondrial complex I inhibitor rotenone triggers a cerebral tauopathy
GU Höglinger et al.
JOURNAL OF NEUROCHEMISTRY (2005)
Clinicopathological features of the tauopathies
B Murray et al.
BIOCHEMICAL SOCIETY TRANSACTIONS (2005)
Tau phosphorylation increases in symptomatic mice overexpressing A30P α-synuclein
M Frasier et al.
EXPERIMENTAL NEUROLOGY (2005)
Parkinson's disease: from causes to mechanisms
O Corti et al.
COMPTES RENDUS BIOLOGIES (2005)
Tyrosine-to-cysteine modification of human α-synuclein enhances protein aggregation and cellular toxicity
WB Zhou et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2004)
Fibrillization of α-synuclein and tau in familial Parkinson's disease caused by the A53T α-synuclein mutation
PT Kotzbauer et al.
EXPERIMENTAL NEUROLOGY (2004)
α-synuclein locus triplication causes Parkinson's disease
AB Singleton et al.
SCIENCE (2003)
Prion peptide induces neuronal cell death through a pathway involving glycogen synthase kinase 3
M Pérez et al.
BIOCHEMICAL JOURNAL (2003)
Initiation and synergistic fibrillization of tau and alpha-synuclein
BI Giasson et al.
SCIENCE (2003)
Golgi fragmentation occurs in the cells with prefibrillar α-synuclein aggregates and precedes the formation of fibrillar inclusion
N Gosavi et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2002)
Loss of response to levodopa in Parkinson's disease and co-occurrence with dementia:: role of D3 and not D2 receptors
JN Joyce et al.
BRAIN RESEARCH (2002)
Office of rare diseases neuropathologic criteria for corticobasal degeneration
DW Dickson et al.
JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY (2002)
Differential neuropathological alterations in transgenic mice expressing α-synuclein from the platelet-derived growth factor and Thy-1 promoters
E Rockenstein et al.
JOURNAL OF NEUROSCIENCE RESEARCH (2002)
Dopaminergic loss and inclusion body formation in α-synuclein mice:: Implications for neurodegenerative disorders
E Masliah et al.
SCIENCE (2000)
Conformational change as one of the earliest alterations of tan in Alzheimer's disease
CL Weaver et al.
NEUROBIOLOGY OF AGING (2000)
分享论文
